DIATHERIX Laboratories, Inc.

Description

Dennis Grimaud, Chairman and CEO Dennis Grimaud brings over 30 years of experience in the health care industry and 20 years experience in biotechnology as an entrepreneur, senior executive and consultant. He is currently Chairman and Chief Executive Officer of Diatherix Laboratories, Inc. a clinical laboratory that provides testing services to healthcare for the identification of infectious disease through multiplexing PCR technology.

Diatherix Laboratories is pleased to provide innovative diagnostic solutions through the use of our new method of PCR testing called TEM-PCR™. This technology allows us to quickly and accurately detect the presence of up to 27 pathogens, along with genetic drug resistances, from one specimen in one day. By accurately identifying the pathogen(s) causing an infection, the appropriate treatment can be prescribed eliminating the prolonged use of unnecessary and ineffective medications.

Diatherix Laboratories, Inc. (DLI) provides clinical laboratory services on a multiplexing platform for the detection of infectious diseases. The testing is based upon molecular differential diagnostics (MDD) for the identification of DNA/RNA for bacteria and viruses. The primary area of focus in infectious disease includes pathogens associated with respiratory infections, Staphylococcus differentiation including MRSA and healthcare associated infections (HAI). DLI has developed a high complexity CLIA certified clinical laboratory to provide services to its target market customers.

Education supports innovation, giving rise to increased professional and economic opportunities. Investment in science and technology education, including hands-on, research-based programs for students and educators, is critical to enabling discoveries that will improve health and keep us competitive.

Fact sheet

Products & services

Similar companies nearby